Eurobio Scientific S.A.
ALERS.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | €81 | €82 | €73 | €71 |
| % Growth | -0.5% | 11.1% | 3.1% | – |
| Cost of Goods Sold | €43 | €45 | €40 | €41 |
| Gross Profit | €38 | €37 | €33 | €31 |
| % Margin | 47% | 44.7% | 45.4% | 43% |
| R&D Expenses | €2 | €2 | €4 | €3 |
| G&A Expenses | €8 | €8 | €8 | €9 |
| SG&A Expenses | €26 | €26 | €19 | €20 |
| Sales & Mktg Exp. | €18 | €12 | €12 | €11 |
| Other Operating Expenses | €5 | €4 | €3 | €5 |
| Operating Expenses | €32 | €32 | €27 | €28 |
| Operating Income | €6 | €9 | €7 | €6 |
| % Margin | 7.1% | 10.6% | 9.3% | 8.5% |
| Other Income/Exp. Net | -€2 | -€8 | -€1 | -€2 |
| Pre-Tax Income | €4 | €0 | €6 | €4 |
| Tax Expense | €1 | €0 | €2 | €1 |
| Net Income | €2 | €0 | €4 | €3 |
| % Margin | 3% | 0% | 5.4% | 3.7% |
| EPS | 0.23 | 0 | 0.4 | 0.29 |
| % Growth | 229,900% | -100% | 37.9% | – |
| EPS Diluted | 0.23 | 0 | 0.4 | 0.22 |
| Weighted Avg Shares Out | 10 | 10 | 10 | 9 |
| Weighted Avg Shares Out Dil | 10 | 10 | 10 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €1 | €1 | -€1 |
| Interest Expense | €2 | €3 | €2 | €2 |
| Depreciation & Amortization | €5 | €2 | €5 | €8 |
| EBITDA | €11 | €8 | €11 | €14 |
| % Margin | 13% | 10% | 15.6% | 19.4% |